iiinova — where your digital self keeps evolving

Reposted by Cindy Birck

multi-memo.bsky.social @multi-memo.bsky.social · 28/01/2026

🎙️Interview Spotlight: Meet Sarah Campill, Public Involvement Officer at @alzheimereurope.bsky.social. In this insightful interview, Sarah shares her experiences working on the Multi-MeMo multinational and interdisciplinary consortium. Read the interview here: www.multi-memo.eu/interview-wi...

042

Reposted by Cindy Birck

Alzheimer Europe @alzheimereurope.bsky.social · 22/01/2026

New paper exploring adherence in the context of research-based multidomain lifestyle interventions to reduce dementia risk, drawing on discussions with members of the EU-FINGERS, Multi-MeMo and LETHE Advisory Boards. Read on: www.alzheimer-europe.org/news/new-pap...

alzheimer-europe.org

New paper explores what “adherence” to dementia risk reduction interventions means to the public

A new open-access perspective article titled “This also matters to me: what does adherence to dementia risk reduction interventions mean to members of

031

Reposted by Cindy Birck

ACCESS-AD @access-ad.bsky.social · 16/01/2026

Earlier this week, we launched ACCESS-AD 🚀 Today, we’re sharing a short video on how our @ihieurope.bsky.social project aims to support earlier diagnosis, safer treatment and better monitoring for #Alzheimer’s disease. 🎬 Watch the video to learn more and stay tuned!

112

Reposted by Cindy Birck

AD-RIDDLE @ad-riddle.bsky.social · 20/01/2026

🧠 Check out this review providing an overview of current clinical applications of fluid, imaging and digital biomarkers for Alzheimer’s disease. @ad-riddle.bsky.social is mentioned as a recent effort to bridge the gap between translational & personalised medicine link.springer.com/article/10.1...

link.springer.com

Clinical translation of fluid, imaging, and digital biomarkers for Alzheimer’s disease - Alzheimer's Research & Therapy

Alzheimer's Research & Therapy - Alzheimer’s disease (AD) is the most common neurodegenerative disorder, affecting millions worldwide. The clinical presentation of AD is heterogenous...

022

Reposted by Cindy Birck

Alzheimer Europe @alzheimereurope.bsky.social · 28/01/2026

Our new report “The Prevalence of Dementia in Europe 2025” provides updated figures for the number of people living with dementia both for Europe as a whole (EU and non-EU), as well as each of the countries within. #DementiaPrevalence #DementiaInEurope www.alzheimer-europe.org/news/new-alz...

168

Reposted by Cindy Birck

Alzheimer Europe @alzheimereurope.bsky.social · 05/01/2026

We wish a very #HappyNewYear2026 to all our friends, colleagues, sponsors, followers, and supporters! To celebrate, we have published our final newsletter of 2025, covering dementia news from across Europe (and beyond) from December. Check it out: bit.ly/AE-newslette...

042

Reposted by Cindy Birck

AD-RIDDLE @ad-riddle.bsky.social · 13/01/2026

🚨NEW paper published in Alzheimer's & Dementia investigating the diagnostic accuracy and clinical utility of key Alzheimer's disease-related plasma biomarkers. Congratulations to all authors👏 @ihieurope.bsky.social Check it out⤵️ alz-journals.onlinelibrary.wiley.com/doi/10.1002/...

alz-journals.onlinelibrary.wiley.com

Enhancing diagnostic precision in Alzheimer's disease: Impact of comorbidities on blood biomarkers for clinical integration

INTRODUCTION Comorbidities may influence Alzheimer's disease (AD) plasma biomarkers. This study aimed to investigate how medical conditions impact AD plasma biomarkers and whether comorbidity-adjust...

032

Reposted by Cindy Birck

Alzheimer Europe @alzheimereurope.bsky.social · 28/10/2025

Did you attend the 35th Alzheimer Europe Conference #35AEC in Bologna earlier this month? Have some feedback to share with the organising team? Please take a few moments to complete the delegate feedback survey, via this link: bit.ly/35AEC_Feedback Closes Friday 31/10!

022

Reposted by Cindy Birck

Alzheimer Europe @alzheimereurope.bsky.social · 08/10/2025

Arrivederci! That's a wrap on #35AEC! Huge thanks to everyone. We loved having all 1,500+ of you there and sharing this great experience with you and co-hosts Federazione Alzheimer Italia and Alzheimer Uniti Italia. Read all about this third and final day: www.alzheimer-europe.org/news/final-d...

0114

Reposted by Cindy Birck

FluiDx-AD @fluidx-ad.bsky.social · 06/10/2025

Ahead of @alzheimereurope.bsky.social #35AEC Bologna: members of the European Working Group of People with Dementia & the European Dementia Carers Working Group are consulting on @fluidx-ad.bsky.social prototype saliva-based screening tests for Alzheimer’s disease risk indication. www.fluidx-ad.eu

063

Reposted by Cindy Birck

Alzheimer Europe @alzheimereurope.bsky.social · 08/10/2025

What a top notch bunch of people! @alzheimereurope.bsky.social in Bologna for #35AEC #GOTEAM

084

Reposted by Cindy Birck

Neil Chadborn @neilchadborn.bsky.social · 08/10/2025

Claire Fyve tells us about her son’s condition Nieman-Picks disease. Known as “childhood Alzheimer’s”. It’s the first time childhood dementia has been presented at Alzheimer Europe Conference #35AEC @alzheimereurope.bsky.social see more info www.childhooddementia.org

childhooddementia.org

Childhood Dementia Initiative

Urgently disrupting the impact of childhood dementia. Childhood Dementia Initiative exists to find answers and better ways to research and treat the 70+ disorders that lead to childhood dementia. Thro...

193

Reposted by Cindy Birck

Innovative Health Initiative @ihieurope.bsky.social · 01/04/2025

📢 4 weeks to the call 9 deadline - the 🕤 is ticking! 🤝 Need consortia partners? Head to our online brokerage platform where you can find other potential applicants & team up! ihicalldays2024.converve.io More info👉 europa.eu/!DQY8t4 #IHITransformingHealth #HealthInnovation #HorizonEU #EUResearch

043

Reposted by Cindy Birck

AMYPAD @imi-amypad.bsky.social · 01/04/2025

✨ Today marks the start of #ADPD2025 in Vienna! If you're attending the conference, don’t miss the AMYPAD, EPAD and EUROPAD-related talks. We hope to see you there to catch up on our latest advancements 🙌

022

Reposted by Cindy Birck

multi-memo.bsky.social @multi-memo.bsky.social · 01/04/2025

Yesterday we hosted our Multi-MeMo General Assembly meeting to discuss key project developments & plan future activities! 📅 This meeting came just ahead of #ADPD2025, where several of our members will be attending and engaging with experts in the field. www.multi-memo.eu/multi-memo-m...

011

Reposted by Cindy Birck

multi-memo.bsky.social @multi-memo.bsky.social · 01/04/2025

📣Several Multi-MeMo partners are attending #ADPD2025 this week in Vienna! We are pleased to be part of this important scientific event! If you are attending the conference, check out our website to know where we can meet our partners⤵️ www.multi-memo.eu/multi-memo-m...

011

Reposted by Cindy Birck

multi-memo.bsky.social @multi-memo.bsky.social · 20/03/2025

Members of the Multi-MeMo Advisory Board met online earlier today to share their views regarding the impact of the new developments in dementia disease-modifying drug treatments and their possible impact on the general population in Europe and preventive programmes www.multi-memo.eu/members-of-t...

011

Reposted by Cindy Birck

AMYPAD @imi-amypad.bsky.social · 24/03/2025

📣 Check out this new article providing a comprehensive review of the pathologic processes reflected by Aβ-PET and CSF biomarkers, their performance, and their current and future applications and contexts of use. Congratulations to all authors 👏 doi.org/10.1002/alz....

doi.org

Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease

Amyloid-β (Aβ) positron emission tomography (PET) imaging and cerebrospinal fluid (CSF) biomarkers are now established tools in the diagnostic workup of patients with Alzheimer's disease (AD), and t...

042

Reposted by Cindy Birck

AMYPAD @imi-amypad.bsky.social · 04/02/2025

📢 Check out this recent opinion piece on the use of Centiloid threshold for anti-amyloid therapy published in The Journal of Prevention of Alzheimer's Disease. Many AMYPAD collaborators are acknowledged for sharing their input on the topic! doi.org/10.1016/j.tj...

031

Reposted by Cindy Birck

EBRAINS @ebrains.bsky.social · 16/01/2025

Register for the EBRAINS Tutorials and Users Day on 12 March in Heidelberg! Newcomers will have the chance to explore the wide range of Open Science tools and services available on the EBRAINS research infrastructure. Find out more: www.ebrains.eu/news-and-eve...

025

Reposted by Cindy Birck

Jean Georges @jeangeorges.bsky.social · 07/01/2025

Here comes my first Bluesky post: Happy to share new exciting job opportunities with Alzheimer Europe - if you have experience and a background in communication, conference organisation or finance, why don't you apply for one of these three positions? www.alzheimer-europe.org/news/we-are-...

alzheimer-europe.org

We are recruiting for three new full-time permanent positions - a Communications Officer, a Conference Coordinator and a Finance Officer

Alzheimer Europe Is looking to immediately fill the following Luxembourg-based positions:

076

Reposted by Cindy Birck

Innovative Health Initiative @ihieurope.bsky.social · 22/01/2025

📣 IHI call 10 is open! DYK the topics contribute to several 🇪🇺 policies, incl. #GreenDeal, #chemicals legislation, #pharmaceutical strategy, #EHDS, #Digital strategy & more! Want to get involved? ▶️ Visit the call webpage europa.eu/!c3xxWb #HorizonEU #IHITransformingHealth #HealthData #HealthResearch

Open IHI calls
IHI call 10
Digital label: one source of comprehensive information for medical technology products
Enabling and safeguarding innovation in secondary use of data in the European Health Data Space (EHDS)
Per- and Poly-fluoroalkyl substance (PFAS) exposure, emissions, and end of life management in the healthcare sector
Deadline for short proposals: 23 April 2025
Find out more: ihi.europa.eu

062